AOD-9604 is a synthetic peptide that was originally developed as a treatment for obesity
In rats given BPC-157, serotonin levels in the brain increase in specific regions while simultaneously decreasing in other regions, such as the hippocampus.[ref] A 2020 study found that BPC-157 reduced leaky gut syndrome by stabilizing gut permeability after NSAID use.[ref] Reducing leaky gut theoretically can affect the gut-brain axis and reduce inflammation
The vitamins used are generally FDA approved, but injections should be administered by a licensed healthcare professional
The labeled ladder is 2.5, 5, 7.5, 10, 12.5, and 15 mg once weekly, with each escalation step held for at least four weeks
Although both compounds are widely investigated in tissue repair research, they examine different biological pathways
Collectively, these effects may contribute to weight loss post-surgery in obese patients, suggesting the functional use of tripeptides for weight loss [182]